Previous 10 | Next 10 |
2023-12-10 08:22:39 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The D...
Published in the Journal of the American Medical Association Network Open, study estimates global COPD burden from 2020 through 2050 Study projects disproportionate growth in COPD among women and low-middle income regions SAN DIEGO, Dec. 07, 2023 (GLOBE NEWSWIRE) -- ResMed (NY...
2023-11-28 16:37:00 ET More on Philips Philips Q3 Earnings: Getting More Attractive (Rating Upgrade) Koninklijke Philips N.V (PHG) Q3 2023 Earnings Call Transcript Koninklijke Philips N.V. 2023 Q3 - Results - Earnings Call Presentation Philips Non-GAAP EPS of...
2023-11-24 12:40:05 ET More on ResMed ResMed: Down 60% With Tremendous Long-Term Potential ResMed: Weight-Loss Drug Worries Provide Buying Opportunity ResMed Inc. (RMD) Q1 2024 Earnings Call Transcript ResMed president & COO Rob Douglas to retire amid sev...
2023-11-19 12:00:00 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly: Perfectly Priced Healthcare Giant Novo Nordisk A/S (NVO) Novo Nordisk R&D Investor Event (Transcript) Eli Lilly: Favorable Developments Continue Regarding Anti-Obesity Drug Franchise ...
2023-11-17 06:49:52 ET More on market strategy S&P 500: Forget The Year-End Rally The Message From 12 Post-CPI Charts SPY: 3 Reasons Not To Believe In This Rally UBS calls for slower growth and rate cuts in 2024 Goldman Sachs channels Taylor Swift...
2023-11-16 23:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-11-12 05:47:32 ET Summary A list of high-quality dividend growth stocks is identified based on proximity to 52-week lows. Pfizer, Bristol-Myers Squibb, ResMed, and NextEra Energy appear attractively valued based on Future and Historical fair valuations. Pfizer appears to ...
2023-11-09 16:51:15 ET More on ResMed ResMed: Down 60% With Tremendous Long-Term Potential ResMed: Weight-Loss Drug Worries Provide Buying Opportunity ResMed Inc. (RMD) Q1 2024 Earnings Call Transcript ResMed stock declines after hours on FQ1 revenue miss, gr...
Justin Leong appointed Chief Product Officer, effective immediately. Katrin Pucknat appointed Chief Marketing Officer, effective immediately. Mike Fliss appointed Chief Revenue Officer, effective immediately. Rob Douglas, President and Chief Operating Officer, to retire Ja...
News, Short Squeeze, Breakout and More Instantly...
2024-06-29 05:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SAN DIEGO, June 10, 2024 (GLOBE NEWSWIRE) -- In collaboration with leading medical researchers from around the world, ResMed (NYSE: RMD, ASX: RMD) presented 13 new clinical studies at SLEEP 2024, the annual joint meeting of the American Academy of Sleep Medicine and the Sleep Research Society. He...
Among 26 ResMed-supported abstracts, these were the highlights: New findings show positive airway pressure (PAP) therapy reduced risks of death and hospitalization for patients with obstructive sleep apnea (OSA) Prevalence of OSA in the United States expected to increase 26.7%...